{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-058063","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.971678+00:00","generated_at":"2026-05-16T01:54:43.332977+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Pediatrix Q4 EPS $0.40; Adj. EPS $0.50; guides 2026 EBITDA $280-300M","bullets":["Net revenue $494M, down slightly YoY; same-unit revenue up 4.0%.","Q4 GAAP net income $33.7M ($0.40/share) vs $30.5M ($0.36) prior year; Adjusted EPS $0.50.","Full year 2025 Adjusted EBITDA $275.6M, up from $224M; Adjusted EPS $2.04 vs $1.51.","Preliminary 2026 Adjusted EBITDA guidance $280-300M, above 2025's $275.6M.","Cash from operations $114.6M in Q4; used $64M for share repurchases; total debt $597M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-058063","json":"https://secwatch.observer/filing/0001193125-26-058063.json","markdown":"https://secwatch.observer/filing/0001193125-26-058063.md","text":"https://secwatch.observer/filing/0001193125-26-058063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/0001193125-26-058063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/md-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:54:43.332977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}